"Miracle Molecule" in cosmetic and beauty industries now available in advanced pet care line from Wondercide called RESCUE™.
AUSTIN, Texas, July 23, 2025 /PRNewswire/ --...
The Trump administration’s latest pirouette in the grand geopolitical ballet with China should come as no surprise to anyone who has observed the capricious...
Organic growth and sequentially higher margin in a weak economy
STOCKHOLM, July 17, 2025 /PRNewswire/ --
Quarter 2, 2025
Net sales decreased 6.6% to SEK 34,185m (36,617)....
Organic growth and sequentially higher margin in a weak economy
STOCKHOLM, July 17, 2025 /PRNewswire/ --
Quarter 2, 2025
Net sales decreased 6.6% to SEK 34,185m (36,617)....
WINNIPEG, Manitoba, July 14, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE) (“Kane Biotech” or “Kane”) announces today that Kane Biotech’s Interim Chief Executive Officer, Dr. Robert Huizinga, will be presenting at the 4th Advanced Wound Care Summit USA taking place from July 15-17, 2025 in Boston, MA.
HOUSTON, July 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and Chief Executive Officer, Pete O’Heeron, will present at the Advanced Wound Care Summit USA in Boston, Massachusetts, on July 15, 2025. The presentation will include recent research advances using fibroblast-based technology for indications such as wound healing and psoriasis.
System built to provide effective body-temperature control; features lock-in hose connection and flexible design
NORTHFIELD, Ill., July 10, 2025 /PRNewswire/ -- Medline today officially announced the...
HOUSTON, July 07, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, is pleased to invite investors to a webinar on July 10, 2025, at 4:15 p.m. ET.
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the release of its Q-FIX KNOTLESS All-Suture Anchor for soft tissue-to-bone fixation indications across multiple joint spaces including Shoulder, Hip, and Foot & Ankle.
Developing nations, drowning in debt, are left to fend for themselves as Washington sits idly by, sipping its oversized latte of indifference. Italy’s Prime...
DELRAY BEACH, Fla., July 4, 2025 /PRNewswire/ --
What's driving the shift from analog to intelligent auscultation?
The global digital stethoscopes market, valued at US$0.49 billion...
DELRAY BEACH, Fla., July 4, 2025 /PRNewswire/ --
What's driving the shift from analog to intelligent auscultation?
The global digital stethoscopes market, valued at US$0.49 billion...